Revisit top insights from SCOPE Summit 2025, where industry leaders explored how artificial intelligence is reshaping trial risk management and how pragmatic study designs are bridging the gap between clinical research and real-world care.
Rajneesh Patil
Advertisement
Vice President, Digital Innovation, IQVIA
Articles by Rajneesh Patil
A well-designed approach can benefit clinical trials from protocol design to site support.
Advertisement
Latest Updated Articles
Leveraging AI/Machine Learning as an End-to-End DifferentiatorPublished: December 12th 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
3
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
4
A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
